The South & Central America Medical Devices is expected to reach US$ 24,642.7 million in 2027 from US$ 17,612.3 million in 2019; it is estimated to grow at a CAGR of 4.4% from 2020 to 2027.
Brazil is the fifth largest country in the world both by area and by population and experiencing the fastest demographic aging worldwide. In Brazil, the aging population is at a rapid pace and in a context of regional and historical socioeconomic inequalities. According to the study conducted in Brazil, the community of women estimated at the vast majority with 16.9 million (56%) of elderly persons, whereas older adults estimated approx. 13.3 million (44%). The growing aging population leads to several chronic conditions such as cancer, orthopedic conditions, neurodegenerative disorders, and diabetes amongst others. Such growing conditions are likely to drive the adoption of medical devices, which will eventually drive the Brazil medical devices market during the forecast period.
Market players in the country are focusing on South & Central America Medical Devices market entry with the help of partnerships and collaborations. For instance, in February 2019, joimax, a Germany-based endoscopes offering company expanded its business operations in Brazil with the help of distribution partner. The company entered into strategic partnership with Brazilian CT Group with an aim to establish brand in Brazil. Further, growing number of product launches are anticipated to offer significant opportunity for market growth. For instance, in July 2018, Novosanis got approval for its Colli-Pee, a non-invasive self-sampling device for urine from ANVISA, Brazilian Health Regulatory authority. Such strategic events are driving the Brazil medical devices market by 2027.
Brazil Medical Devices Market Revenue and Forecast to 2027 (US$ Million)

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
SOUTH & CENTRAL AMERICA MEDICAL DEVICES – MARKET SEGMENTATION
By Product Type
- In Vitro Diagnostics (IVD)
- Surgical Device
- Minimally invasive surgery instruments
- Electrosurgical Generators
- Ultrasonic Surgical Generators
- Others
- General Medical devices
- Cardivascular devices
- Orthopedic
- Infection control devices
- Ophthalmology
- Endoscopy
- Neurology
- Others
By Function
- Diagnostic and Monitoring
- Surgical
- Therapeutics
- Others
By End Use
- Hospital
- Ambulatory Care
- Homecare
- Others
By Country
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Medtronic
- Abbott
- Boston Scientific Corporation
- Braun Melsungen AG
- 3M
- General Electric Company
- Stryker Corporation
- Koninklijke Philips N.V.
- Siemens AG;
- Johnson and Johnson Services, Inc.
South & Central America Medical Devices Report Scope
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 17,612.3 Million |
Market Size by 2027 | US$ 24,642.7 Million |
Global CAGR (2020 - 2027) | 4.4% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Product Type
|
Regions and Countries Covered | South and Central America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















- Medtronic
- Abbott
- Boston Scientific Corporation
- Braun Melsungen AG
- 3M
- General Electric Company
- Stryker Corporation
- Koninklijke Philips N.V.
- Siemens AG;
- Johnson and Johnson Services, Inc.


